Gentherm Inc

Gentherm Inc(THRM)股票分析

$28.610

-0.423 (-1.48%)收盤時

Loading chart…
最高
29.320
開盤
28.950
成交量加權均價
28.80
成交量
1.55M
市值
1.55B
最低
28.470
成交金額
44.62M
企業價值/稅息折舊攤銷前利潤(TTM)
9.56

Gentherm Incorporated is a provider of thermal and precision flow management technologies. The Automotive reporting segment comprises global automotive businesses, including the design, development, manufacturing and sales of its automotive climate and comfort solutions (including Climate Control Seats, Climate Control Interiors, and others), Valve Systems and other automotive products. The Medical reporting segment comprises the patient temperature management business in the medical industry. Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and additional warming/cooling therapies utilized in acute and chronic care departments and non-hospital facilities. It also offers highly engineered, mission-critical thermal solutions serving commercial vehicles, off-highway equipment, light vehicle and power generation markets.

AI 分析 of Gentherm Inc (THRM)

持有

Gentherm Inc (THRM) is currently priced at $29.04, which is significantly below the analyst price target of $48 from JPMorgan, indicating a potential upside of approximately 65%. However, the stock has a low RSI of 24.39, suggesting it is oversold, but the recent trend shows a 20.11% decline over the last 20 days, indicating ongoing weakness. The significant increase in hedge fund selling by 8556.93% raises concerns about market sentiment. Therefore, while there is potential for recovery, the risks are substantial and a hold is recommended for now.

分析師評級(9)

上檔空間 +51.45%
買進
5 買進
4 持有
0 賣出
目前: 28.61
最低
42.00
平均
43.33
最高
44.00

JPMorgan

2026-09-15

目標價

$48

增持

CJS Securities

2026-09-14

目標價

$50

優於大盤

Roth Capital

2026-07-29

目標價

$50

買進

Freedom Broker

2026-07-24

目標價

$40

持有

JPMorgan

2026-07-24

目標價

$48

中性

估值指標

Gentherm Inc(THRM)目前預期本益比為 11.09,5 年平均預期本益比為 20.07。

預期本益比

合理
5 年均值 P/E
20.07
目前P/E
11.09
高估
29.21
低估
10.94

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
9.83
目前EV/EBITDA
9.56
高估
13.99
低估
5.67

預期股價營收比

合理
5 年均值 P/S
1.16
目前P/S
0.93
高估
1.70
低估
0.62

Alphio AI 對 THRM 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%THRM

$35.25

情境價格

基

基準

基準 · 50%THRM

$31.57

情境價格

悲

悲觀

悲觀 · 25%THRM

$29.03

情境價格

持有 THRM 的大戶

G

Global Alpha Capital Management Ltd.

+ 持有THRM

-4.31%

3個月報酬率

S

Segall Bryant & Hamill, LLC

+ 持有THRM

-4.76%

3個月報酬率

事件時間軸

2026-09-17 (ET)

17:00:00

Gentherm and Modine Complete Merger Transaction, Distributing $58.35 Million Cash Dividend

2026-09-10 (ET)

13:30:00

Gentherm Shareholders Approve Merger with Modine

2026-07-23 (ET)

06:30:00

Gentherm Reports Q2 Revenue of $416.2M

06:30:00

FY26 Revenue Consensus at $1.56B, Adjusted EBITDA View Raised to $185M-$200M

06:30:00

Board Approves New $400M Stock Repurchase Program

資訊

THRM 常見問題 —— 由 Alphio AI 解答

Gentherm Incorporated is a provider of thermal and precision flow management technologies. The Automotive reporting segment comprises global automotive businesses, including the design, development, manufacturing and sales of its automotive climate and comfort solutions (including Climate Control Seats, Climate Control Interiors, and others), Valve Systems and other automotive products. The Medical reporting segment comprises the patient temperature management business in the medical industry. Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and additional warming/cooling therapies utilized in acute and chronic care departments and non-hospital facilities. It also offers highly engineered, mission-critical thermal solutions serving commercial vehicles, off-highway equipment, light vehicle and power generation markets. It operates in the Consumer Cyclicals sector (MOTOR VEHICLE PARTS & ACCESSORIES industry).

Gentherm Inc (THRM) is currently priced at $29.04, which is significantly below the analyst price target of $48 from JPMorgan, indicating a potential upside of approximately 65%. However, the stock has a low RSI of 24.39, suggesting it is oversold, but the recent trend shows a 20.11% decline over the last 20 days, indicating ongoing weakness. The significant increase in hedge fund selling by 8556.93% raises concerns about market sentiment. Therefore, while there is potential for recovery, the risks are substantial and a hold is recommended for now.

9 analysts cover THRM: 5 rate it Buy, 4 Hold and 0 Sell. The average price target is 43.33.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易